News and Events

Our AI-driven approach combines docking with Active Learning (AL), which addresses these challenges by intelligently guiding the search for promising compounds, performing only a fraction of the calculations.

VAV1 has re-emerged as a focus of interest for pharmaceutical companies due to its high potential role in the pathogenesis of autoimmune diseases.

Last Chance: Custom Compound Library for Just $10K!
This is your final opportunity to get a custom-designed compound library tailored to your target - for only $10K.

Every year, July 28 marks World Hepatitis Day – a global call to raise awareness, promote prevention, improve diagnosis, and expand access to treatment for all forms of viral hepatitis.

Lactate dehydrogenase A (LDHA) is a promising target in drug discovery due to its central role in glycolysis. Chemspace offers a carefully selected set of Biologics for studying LDHA.

On July 22, we celebrate World Brain Day, honoring the founding of the World Federation of Neurology and uniting the global community to promote brain health.

Following the screening of 3.9M compounds, we curated a library of 528 potent and novel type II kinase inhibitors.

Chemspace, LLC, Enamine, Ltd., and Orogen Therapeutics are excited to announce a strategic collaboration to enable next-generation REAL-driven DNA-encoded small molecule libraries (DELs). This partnership brings together the complementary strengths of the three companies to accelerate the search for innovative medicines.

We are excited to announce that Freedom Space 4.0 is now accessible for screening using Alipheron’s latest powerful tool, Pharos-3D.

Handling ultra-large chemical spaces like Enamine REAL Space (70B) or Chemspace Freedom Space 4.0 (142B) using traditional enumeration and scoring methods can take weeks and massive computing power.

Over the past few years, commercially available combinatorial libraries have expanded from billions to trillions of compounds, posing a fundamental computational and methodological challenge: how to explore such massive spaces efficiently and meaningfully? 

Great News! Chemspace databases are now searchable on the CHEESE Platform!

We are thrilled to announce our partnership with QDX, pioneers in revolutionizing molecular research through advanced computational technologies.

Thanks to everyone who joined us on Thursday for the webinar with Prof. Vsevolod Katritch! 

We are excited to announce the upcoming Chemspace webinar co-hosted with Vsevolod Katritch: "Making the First Move: Efficient Hit and Lead Discovery Using Combinatorial Spaces with V-SYNTHES"!
 

We are thrilled to share that Rita Gaidar will be attending the 4th RSC Anglo-Nordic Medicinal Chemistry Symposium, taking place from June 10 to 13 in Denmark.

Heading to the 13th International Conference on Chemical Structure, June 1–5? So are we! Meet Olga Tarkhanova, PhD, and Anna Kapeliukha who will be sharing their latest research.

We are excited to announce that Elena Mishchuk, PhD and Kateryna Horbatok, MSc will be attending BioMed Israel 2025 in Tel Aviv on May 20–22!

Our team has designed a GPCR Targeted Library using USRCAT-based ligand similarity, bringing together 112,000+ diverse compounds predicted to act on 182 targets across 65 GPCR families.

Join Kateryna Horbatok, our Project Manager, at the upcoming workshop "Challenges in GPCR Drug Discovery," co-organized by AstraZeneca and InSingulo!

AsedaSciences Partners with Chemspace to Visualize 13 Billion Compounds on 3RnD® Cloud Platform.

We are excited to announce that Elena Mishchuk and Inna Volkova will be attending the Bio Korea 2025 International Convention!

Suzetrigine (VX-548, Journavx®), the first-in-class oral NaV1.8 inhibitor developed by Vertex Pharmaceuticals and approved by the FDA in January 2025, was named Molecule of the Year 2024 by Drug Hunter.

Earlier, Chemspace represented the M1 mAChR Biologics set, and now we are introducing a carefully selected set for studying the M4 mAChR!

Now you can search across 142 billion molecules - easily and free of charge!